Design of translactam HCMV protease inhi
β
Alan D. Borthwick
π
Article
π
2005
π
John Wiley and Sons
π
English
β 908 KB
## Abstract Human cytomegalovirus (HCMV) is an important pathogen for which there is a significant unmet medical need. New HCMV antivirals, active against novel molecular targets, are undoubtedly needed as the currently available drugs ganciclovir, cidofovir, and foscarnet, which are all viral DNA